KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Capital Expenditures (2017 - 2025)

Guardant Health's Capital Expenditures history spans 9 years, with the latest figure at -$16.3 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 31.82% year-over-year to -$16.3 million; the TTM value through Dec 2025 reached $4.1 million, up 7.93%, while the annual FY2025 figure was $4.1 million, 7.93% up from the prior year.
  • Capital Expenditures for Q4 2025 was -$16.3 million at Guardant Health, down from $10.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $40.1 million in Q3 2021 and bottomed at -$16.3 million in Q4 2025.
  • The 5-year median for Capital Expenditures is $4.8 million (2024), against an average of $5.6 million.
  • The largest annual shift saw Capital Expenditures plummeted 505.41% in 2022 before it skyrocketed 754.41% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $24.6 million in 2021, then crashed by 102.53% to -$623000.0 in 2022, then surged by 754.41% to $4.1 million in 2023, then crashed by 404.17% to -$12.4 million in 2024, then plummeted by 31.82% to -$16.3 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Capital Expenditures are -$16.3 million (Q4 2025), $10.4 million (Q3 2025), and $5.6 million (Q2 2025).